Danda Trouve Investment Management, Inc. Abb Vie Inc. Transaction History
Danda Trouve Investment Management, Inc.
- $54.1 Million
- Q3 2022
A detailed history of Danda Trouve Investment Management, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Danda Trouve Investment Management, Inc. holds 371 shares of ABBV stock, worth $70,234. This represents 0.09% of its overall portfolio holdings.
Number of Shares
371
Previous 371
-0.0%
Holding current value
$70,234
Previous $57,000
12.28%
% of portfolio
0.09%
Previous 0.09%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,253Shares Held
1.27BCall Options Held
16.5MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA174MShares$32.9 Billion0.68% of portfolio
-
Black Rock Inc. New York, NY136MShares$25.8 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.1 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.4 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$7.79 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $335B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...